These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8461554)

  • 21. Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
    Gorai I; Chaki O; Taguchi Y; Nakayama M; Osada H; Suzuki N; Katagiri N; Misu Y; Minaguchi H
    Calcif Tissue Int; 1999 Jul; 65(1):16-22. PubMed ID: 10369728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis.
    Yamada Y; Harada A; Hosoi T; Miyauchi A; Ikeda K; Ohta H; Shiraki M
    J Bone Miner Res; 2000 Mar; 15(3):415-20. PubMed ID: 10750555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF
    Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of vitamin D and its metabolites in the pathogenesis and therapy of osteoporosis].
    Scharla SH; Ziegler R
    Dtsch Med Wochenschr; 1994 Jun; 119(23):847-51. PubMed ID: 8005057
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of postmenopausal osteoporosis with 1-alpha(OH)D3].
    Petkakov M; Popović V; Milić D; Damjanović S; Manojlović D; Mićić J
    Srp Arh Celok Lek; 1995; 123(7-8):171-3. PubMed ID: 17974421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
    Yamanishi A; Ishibashi Y; Kuriyama K; Tachiiri T; Kusajima H; Kojima E; Momo K
    Nihon Yakurigaku Zasshi; 1999 Jan; 113(1):55-65. PubMed ID: 10096106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years.
    Sairanen S; Kärkkäinen M; Tähtelä R; Laitinen K; Mäkelä P; Lamberg-Allardt C; Välimäki MJ
    Calcif Tissue Int; 2000 Aug; 67(2):122-7. PubMed ID: 10920216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
    Gallagher JC; Goldgar D
    Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
    Gallagher JC
    J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alfacalcidol (alpha D3) and calcium in osteoporosis.
    Menczel J; Foldes J; Steinberg R; Leichter I; Shalita B; Bdolah-Abram T; Kadosh S; Mazor Z; Ladkani D
    Clin Orthop Relat Res; 1994 Mar; (300):241-7. PubMed ID: 8131343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD; Farahmand P; Schacht E; Rozehnal A
    Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women.
    Need AG; Kemp A; Giles N; Morris HA; Horowitz M; Nordin BE
    Osteoporos Int; 2002 Jan; 13(1):83-8. PubMed ID: 11883410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.
    Neer M; Slovik DM; Daly M; Potts T; Nussbaum SR
    Osteoporos Int; 1993; 3 Suppl 1():204-5. PubMed ID: 8461561
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
    Dechant KL; Goa KL
    Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
    Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
    Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
    Richy F; Ethgen O; Bruyere O; Reginster JY
    Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.